HCA Healthcare (HCA) and The Competition Financial Comparison

HCA Healthcare (NYSE:HCA) is one of 233 public companies in the “Healthcare Providers & Services” industry, but how does it compare to its rivals? We will compare HCA Healthcare to similar companies based on the strength of its institutional ownership, valuation, dividends, earnings, analyst recommendations, risk and profitability.

Earnings and Valuation

This table compares HCA Healthcare and its rivals revenue, earnings per share and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
HCA Healthcare	$75.60 billion	$6.78 billion	16.55
HCA Healthcare Competitors	$21.12 billion	$301.67 million	-1.71

HCA Healthcare has higher revenue and earnings than its rivals. HCA Healthcare is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Dividends

HCA Healthcare pays an annual dividend of $3.12 per share and has a dividend yield of 0.6%. HCA Healthcare pays out 10.3% of its earnings in the form of a dividend. As a group, “Healthcare Providers & Services” companies pay a dividend yield of 1.4% and pay out 24.7% of their earnings in the form of a dividend. HCA Healthcare has increased its dividend for 6 consecutive years.

Analyst Ratings

This is a summary of recent ratings and target prices for HCA Healthcare and its rivals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
HCA Healthcare	1	7	16	0	2.62
HCA Healthcare Competitors	1873	7747	13373	829	2.55

HCA Healthcare currently has a consensus target price of $480.13, suggesting a potential downside of 3.89%. As a group, “Healthcare Providers & Services” companies have a potential upside of 15.25%. Given HCA Healthcare’s rivals higher possible upside, analysts plainly believe HCA Healthcare has less favorable growth aspects than its rivals.

Institutional & Insider Ownership

62.7% of HCA Healthcare shares are owned by institutional investors. Comparatively, 56.7% of shares of all “Healthcare Providers & Services” companies are owned by institutional investors. 1.5% of HCA Healthcare shares are owned by company insiders. Comparatively, 15.0% of shares of all “Healthcare Providers & Services” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk and Volatility

HCA Healthcare has a beta of 1.11, suggesting that its share price is 11% more volatile than the S&P 500. Comparatively, HCA Healthcare’s rivals have a beta of 0.98, suggesting that their average share price is 2% less volatile than the S&P 500.

Profitability

This table compares HCA Healthcare and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
HCA Healthcare	8.61%	-198.52%	10.81%
HCA Healthcare Competitors	-8.06%	-136.95%	-1.64%

Summary

HCA Healthcare beats its rivals on 10 of the 15 factors compared.

About HCA Healthcare

HCA Healthcare is a healthcare services company that operates hospitals and other care facilities. Its services include inpatient and outpatient care, emergency treatment, surgery, diagnostic services and specialized care across areas such as cancer and cardiovascular medicine. The company serves patients in the United States and the United Kingdom through its network of hospitals and outpatient facilities, including surgery centers, urgent care clinics and physician practices. Founded in 1968, HCA Healthcare is headquartered in Nashville, Tennessee.